WA regenerative medicine company Orthocell has reported a near 100 per cent success rate for its dental bone repair product during a recent clinical study.
Striate+, manufactured at Orthocell’s Murdoch facility, is a resorbable collagen membrane used for guided bone and tissue generation in dental procedures. The product is distributed globally by one of the world’s largest dental implant companies, BioHorizons.
Subscribers with digital access can view this article.
Already a subscriber?
Source Agencies
